AngioDynamics, Inc. ANGO recently announced the completion of the sale of its PICC and Midline product portfolios to Spectrum Vascular for $45 million in cash. AngioDynamics' PICC, Midline, and tip ...

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...

The incidence of catheter-related bloodstream infections was low in patients with midline vs peripherally inserted central catheters, but the use of midline catheters was associated with increased ...

Increased utilization of midline catheters not associated with a decreased risk of deep vein thrombosis or sepsis when compared with PICC lines The old, outdated central lines, PICC lines, and ...

BILLERICA, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. (AVI), a leader in tackling critical vascular access challenges with its advanced hydrophilic biomaterial technology, today announced findings ...

BEDFORD, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. today announced FDA clearance of its HydroMID™ midline catheter. HydroMID, which is made of Access Vascular’s proprietary biomaterial that has ...

Midline catheters and vascular access devices (VADs) play a pivotal role in modern clinical practice by offering less invasive alternatives to central venous access. Midline catheters, which are ...

Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter Access Vascular, Inc. (AVI), a leader in ...